PepGen (PEPG) Competitors $1.33 +0.10 (+8.13%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.32 -0.01 (-0.38%) As of 04/17/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PEPG vs. DERM, OGI, LYEL, SCPH, ACRS, PRQR, RAPT, GLSI, FDMT, and NKTXShould you be buying PepGen stock or one of its competitors? The main competitors of PepGen include Journey Medical (DERM), Organigram (OGI), Lyell Immunopharma (LYEL), scPharmaceuticals (SCPH), Aclaris Therapeutics (ACRS), ProQR Therapeutics (PRQR), RAPT Therapeutics (RAPT), Greenwich LifeSciences (GLSI), 4D Molecular Therapeutics (FDMT), and Nkarta (NKTX). These companies are all part of the "pharmaceutical products" industry. PepGen vs. Journey Medical Organigram Lyell Immunopharma scPharmaceuticals Aclaris Therapeutics ProQR Therapeutics RAPT Therapeutics Greenwich LifeSciences 4D Molecular Therapeutics Nkarta PepGen (NASDAQ:PEPG) and Journey Medical (NASDAQ:DERM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership. Is PEPG or DERM more profitable? PepGen has a net margin of 0.00% compared to Journey Medical's net margin of -31.74%. PepGen's return on equity of -60.17% beat Journey Medical's return on equity.Company Net Margins Return on Equity Return on Assets PepGenN/A -60.17% -48.88% Journey Medical -31.74%-132.10%-26.90% Do analysts rate PEPG or DERM? PepGen presently has a consensus target price of $10.33, suggesting a potential upside of 676.94%. Journey Medical has a consensus target price of $9.88, suggesting a potential upside of 58.00%. Given PepGen's higher probable upside, equities analysts clearly believe PepGen is more favorable than Journey Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PepGen 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Journey Medical 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Do insiders and institutionals hold more shares of PEPG or DERM? 58.0% of PepGen shares are held by institutional investors. Comparatively, 7.3% of Journey Medical shares are held by institutional investors. 4.6% of PepGen shares are held by company insiders. Comparatively, 13.2% of Journey Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, PEPG or DERM? PepGen has a beta of 1.42, indicating that its share price is 42% more volatile than the S&P 500. Comparatively, Journey Medical has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Does the media prefer PEPG or DERM? In the previous week, PepGen had 1 more articles in the media than Journey Medical. MarketBeat recorded 2 mentions for PepGen and 1 mentions for Journey Medical. PepGen's average media sentiment score of 0.66 beat Journey Medical's score of -1.00 indicating that PepGen is being referred to more favorably in the media. Company Overall Sentiment PepGen Positive Journey Medical Negative Which has preferable earnings and valuation, PEPG or DERM? Journey Medical has higher revenue and earnings than PepGen. Journey Medical is trading at a lower price-to-earnings ratio than PepGen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPepGenN/AN/A-$78.63M-$2.84-0.47Journey Medical$56.13M2.57-$3.85M-$0.74-8.45 Does the MarketBeat Community favor PEPG or DERM? PepGen received 14 more outperform votes than Journey Medical when rated by MarketBeat users. However, 85.71% of users gave Journey Medical an outperform vote while only 80.00% of users gave PepGen an outperform vote. CompanyUnderperformOutperformPepGenOutperform Votes2080.00% Underperform Votes520.00% Journey MedicalOutperform Votes685.71% Underperform Votes114.29% SummaryPepGen and Journey Medical tied by winning 9 of the 18 factors compared between the two stocks. Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PEPG vs. The Competition Export to ExcelMetricPepGenPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$43.48M$6.45B$5.30B$7.34BDividend YieldN/A3.23%5.12%4.30%P/E Ratio-0.456.8921.8017.78Price / SalesN/A231.03379.9697.74Price / CashN/A65.6738.2634.64Price / Book0.295.916.443.97Net Income-$78.63M$142.72M$3.21B$247.65M7 Day Performance17.70%4.38%2.85%1.80%1 Month Performance-38.99%-12.76%-8.64%-6.98%1 Year Performance-88.77%-9.69%11.38%1.34% PepGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PEPGPepGen2.6914 of 5 stars$1.33+8.1%$10.33+676.9%-88.4%$43.48MN/A-0.4530DERMJourney Medical2.213 of 5 stars$6.21+3.0%$9.88+59.0%+61.9%$143.48M$56.13M-6.6190Short Interest ↑OGIOrganigram0.5627 of 5 stars$1.04+1.0%N/A-41.5%$131.31M$166.12M-2.74860LYELLyell Immunopharma3.1963 of 5 stars$0.44+1.4%$1.00+124.9%-81.8%$131.26M$61,000.00-0.56270Analyst ForecastGap DownSCPHscPharmaceuticals3.7392 of 5 stars$2.58+11.2%$14.00+442.6%-41.9%$129.73M$36.33M-1.3630Short Interest ↓Gap DownACRSAclaris Therapeutics1.8451 of 5 stars$1.18+2.6%$11.67+888.7%-7.3%$127.34M$18.72M-2.27100Gap DownPRQRProQR Therapeutics2.375 of 5 stars$1.18+5.4%$9.50+705.1%-40.0%$124.15M$18.91M-3.69180Short Interest ↓News CoverageRAPTRAPT Therapeutics3.6138 of 5 stars$0.93+7.2%$4.00+332.0%-90.2%$122.24M$1.53M-0.3380Short Interest ↑News CoverageGLSIGreenwich LifeSciences1.597 of 5 stars$9.28-5.9%$38.00+309.5%-31.4%$121.99MN/A-11.603Earnings ReportUpcoming EarningsGap DownHigh Trading VolumeFDMT4D Molecular Therapeutics2.7831 of 5 stars$2.78+5.7%$26.71+860.9%-87.9%$121.77M$37,000.00-0.98120Analyst RevisionNews CoverageNKTXNkarta2.8595 of 5 stars$1.70+7.9%$14.86+773.9%-77.0%$120.63MN/A-0.90140Short Interest ↓Gap Down Related Companies and Tools Related Companies Journey Medical Alternatives Organigram Alternatives Lyell Immunopharma Alternatives scPharmaceuticals Alternatives Aclaris Therapeutics Alternatives ProQR Therapeutics Alternatives RAPT Therapeutics Alternatives Greenwich LifeSciences Alternatives 4D Molecular Therapeutics Alternatives Nkarta Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PEPG) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PEPG Stock Free PEPG Stock Alerts